CiteFacts · FDA Drug Shortages · FDA source

FDA shortage status: Methylphenidate Film, Extended Release

FDA shortage status · Source checked 2026-10-06T18:55:41+00:00

FDA source answer

FDA currently lists this ingredient in shortage.

FDA source statuses: Current. First FDA posting: 2025-02-28. Latest FDA row update: 2026-09-02.

FDA lists 4 package records, with companies: Noven Pharmaceuticals, Inc., PADAGIS US LLC. Package NDCs: 0574-2410-65, 0574-2415-65, 0574-2420-65, 0574-2430-65.

FDA shortage reason: Not stated in the grouped FDA source rows.

This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.

FDA package and manufacturer records

CompanyPackage NDCPresentationFDA availability fieldFDA update
Noven Pharmaceuticals, Inc.0574-2410-65Methylphenidate, Film, Extended Release, 10 mg (NDC 0574-2410-65)Available2026-09-02
Noven Pharmaceuticals, Inc.0574-2415-65Methylphenidate, Film, Extended Release, 15 mg (NDC 0574-2415-65)Available2026-09-02
Noven Pharmaceuticals, Inc.0574-2420-65Methylphenidate, Film, Extended Release, 20 mg (NDC 0574-2420-65)Available2026-09-02
Noven Pharmaceuticals, Inc.0574-2430-65Methylphenidate, Film, Extended Release, 30 mg (NDC 0574-2430-65)Available2026-09-02

Source facts

Grouped generic ingredient: Methylphenidate Film, Extended Release · 4 package records

Therapeutic categories: Psychiatry
Dosage forms: Film, Extended Release
Routes: TRANSDERMAL

Open FDA source data · JSON · Markdown

FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.